NCT04544774

The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy

The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy: An Academic Multicentre Clinical Study

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 200 (estimated)
• Sponsor: Universitaire Ziekenhuizen KU Leuven · Academic / Other
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: —

Summary

This prospective multicentric academic NAPT study aims to compile a database of all patients who initiate immunotherapy. The NAPT will take place before, during and after AIT to evaluate the cost and effectiveness of the treatment. The study consists of 4 visits and 2 telephone contacts that are repeated annually for 3 years. This study will be conducted in 2 hospitals: UZ Leuven and AZ ST. Jan Brugge on the consultation Ear, Nose and Throat Diseases (ENT) and the department of Internal Medicine / Allergology

Conditions

• Perennial Allergic Rhinitis
• Seasonal Allergic Rhinitis
• Local Allergic Rhinitis

Interventions

Type	Name	Description
DRUG	AIT	AIT for airborn allergens (SCIT/SLIT)
DIAGNOSTIC_TEST	NAPT	NAPT test with airborn allergens ( HDM, Threes, Grasses)

Timeline

• Start date: 2020-07-16
• Primary completion: 2025-12-01
• Completion: 2025-12-01
• First posted: 2020-09-10
• Last updated: 2020-09-10

Locations

2 sites across 1 country: Belgium